These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31811620)

  • 1. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.
    Carreras JJ; Tapia-Ramirez WE; Sala A; Guillot AJ; Garrigues TM; Melero A
    Drug Deliv Transl Res; 2020 Apr; 10(2):486-497. PubMed ID: 31811620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A.
    Verma DD; Fahr A
    J Control Release; 2004 May; 97(1):55-66. PubMed ID: 15147804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and
    Walunj M; Doppalapudi S; Bulbake U; Khan W
    J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of Microneedle-assisted skin delivery of cyanocobalamin formulated in ultraflexible lipid vesicles.
    Guillot AJ; Merino-Gutiérrez P; Bocchino A; O'Mahony C; Giner RM; Recio MC; Garrigues TM; Melero A
    Eur J Pharm Biopharm; 2022 Aug; 177():184-198. PubMed ID: 35787430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
    Yang ZQ; Xu J; Pan P; Zhang XN
    Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles.
    Guillot AJ; Jornet-Mollá E; Landsberg N; Milián-Guimerá C; Montesinos MC; Garrigues TM; Melero A
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33804652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
    Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
    Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
    Guan P; Lu Y; Qi J; Wu W
    Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin.
    Trombino S; Servidio C; Laganà AS; Conforti F; Marrelli M; Cassano R
    Molecules; 2020 Aug; 25(15):. PubMed ID: 32748846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles.
    Jeong HR; Kim JY; Kim SN; Park JH
    Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib.
    Bragagni M; Mennini N; Maestrelli F; Cirri M; Mura P
    Drug Deliv; 2012; 19(7):354-61. PubMed ID: 23043648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
    Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation.
    Guo F; Wang J; Ma M; Tan F; Li N
    J Mater Sci Mater Med; 2015 Apr; 26(4):175. PubMed ID: 25825320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
    Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
    Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
    Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ
    Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
    Sharma G; Goyal H; Thakur K; Raza K; Katare OP
    Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
    Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C
    J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
    Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY
    Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
    Chacón M; Molpeceres J; Berges L; Guzmán M; Aberturas MR
    Eur J Pharm Sci; 1999 May; 8(2):99-107. PubMed ID: 10210732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.
    El Zaafarany GM; Awad GA; Holayel SM; Mortada ND
    Int J Pharm; 2010 Sep; 397(1-2):164-72. PubMed ID: 20599487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.